Speaker Details

speaker photo

Jack Jacobs

President

Zhittya Genesis Medicine Inc.

About

Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, Multiple sclerosis, and enhance stroke recovery.

Content from Jack Jacobs

Keyword Image

Angiogenesis As Breakthrough Therapy for the Treatment of Heart Disease, Peripheral Artery Disease (PAD), and Diabetic Foot Ulcers

06/25/2019 12:00 am EST

...

Keyword Image

Parkinson's Disease, Stroke Recovery, Alzheimer's Disease, ALS, and more: Is Angiogenesis a Treatment or Even a Possible Cure?

06/21/2019 12:00 am EST

...

Keyword Image

New Frontiers in Healthcare: Disease Reversal Through Angiogenesis

05/30/2019 12:00 am EST

Over 75 human diseases are known to result from lack of blood flow to a tissue or an organ. Learn ho...

Keyword Image

Using Biotech to Conquer Human Diseases

05/28/2019 12:00 am EST

New regenerative biopharmaceutical products are now under clinical development to stimulate the body...

View All from Jack Jacobs